LONG-TERM EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA BY BASELINE BODY MASS INDEX

被引：2
作者：
Chupp, Geoffrey L.
Lugogo, Njira L.
Wechsler, Michael E.
Lawson, Kaitlyn
Lindsley, Andrew
Spahn, Joe D.
Ambrose, Christopher
机构：
来源：
CHEST | 2023年 / 164卷 / 04期
关键词：
D O I：
10.1016/j.chest.2023.07.075
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：9A / 14A
页数：6
相关论文
共 50 条
  • [21] Efficacy Of Tezepelumab In Patients With Severe, Uncontrolled Asthma By Specific Perennial Allergen Immunoglobulin E Thresholds
    Lindsley, Andrew
    Colice, Gene
    Martin, Neil
    Spahn, Joseph
    Martin, Nicole
    Ambrose, Chris
    Hoyte, Flavia
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB18 - AB18
  • [22] EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA AND ALLERGIC RHINITIS GROUPED BY BASELINE BLOOD EOSINOPHIL COUNT: POOLED ANALYSIS OF PATHWAY AND NAVIGATOR
    Wechsler, Michael E.
    Chupp, Geoffrey L.
    Israel, Elliot
    Castro, Mario
    Bober, Magdalena
    Lindsley, Andrew
    Spahn, Joe D.
    Ambrose, Christopher S.
    CHEST, 2024, 166 (04) : 4664A - 4680A
  • [23] Population Pharmacokinetic Modeling and Exposure-Efficacy and Body Weight-Response Analyses for Tezepelumab in Patients With Severe, Uncontrolled Asthma
    Zheng, Yanan
    Abuqayyas, Lubna
    Quartino, Angelica
    Guan, Ye
    Gao, Yuying
    Liu, Lu
    Hellqvist, Asa
    Colice, Gene
    Macdonald, Alexander
    JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 64 (08) : 908 - 921
  • [24] Impact of Body Mass Index on Efficacy of Benralizumab in Patients with Severe, Uncontrolled Eosinophilic Asthma: Pooled Analysis of the SIROCCO and CALIMA Trials
    Trudo, F.
    Hirsch, I.
    Gopalan, G.
    Martin, U.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [25] Efficacy and safety of tezepelumab in patients with uncontrolled disease while receiving maintenance therapy for moderate or severe asthma
    Corren, Jonathan
    Wechsler, Michael E.
    Chupp, Geoffrey
    Roseti, Stephanie L.
    Hellqvist, Asa
    Martin, Neil
    Llanos, Jean -Pierre
    Ambrose, Christopher S.
    Colice, Gene
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2023, 11 (03) : 943 - +
  • [26] Efficacy of Tezepelumab in Patients With Severe, Uncontrolled Asthma by Sex: Results From the Phase 3 Navigator Study
    Kraft, M.
    Chupp, G. L.
    Reeh, K.
    Lindsley, A. W.
    Cook, B.
    Hunter, G.
    Ambrose, C. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [27] Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma Across Multiple Clinically Relevant Subgroups in the NAVIGATOR Study
    Carr, Tara F.
    Moore, Wendy C.
    Kraft, Monica
    Brusselle, Guy
    Castro, Mario
    Chupp, Geoffrey L.
    Wechsler, Michael E.
    Hunter, Gillian
    Lindsley, Andrew W.
    Llanos, Jean-Pierre
    Burke, Luke K.
    Chandarana, Shradha
    Ambrose, Christopher S.
    ADVANCES IN THERAPY, 2024, 41 (07) : 2978 - 2990
  • [28] Tezepelumab can restore normal lung function in patients with severe, uncontrolled asthma
    Pavord, Ian Douglas
    Brightling, Christopher E.
    Korn, Stephanie
    Martin, Nicole
    Ponnarambil, Sandhia
    Molfino, Nestor A.
    Parnes, Jane R.
    Cook, Bill
    Ambrose, Christopher S.
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [29] Efficacy of tezepelumab in patients with severe, uncontrolled asthma, according to baseline blood eosinophil count and allergic status: results from the phase 3 NAVIGATOR study
    Menzies-Gow, A.
    Corren, J.
    Cook, B.
    Kmita, K.
    Llanos-Ackert, J.
    Colice, G.
    Ambrose, C. S.
    ALLERGY, 2021, 76 : 21 - 22
  • [30] Evaluation of long-term safety and efficacy of omalizumab in elderly patients with uncontrolled allergic asthma
    Tat, Tugba Songul
    Cilli, Aykut
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : 546 - 549
12345